Delayed
Borsa Istanbul
02:46:30 03/07/2024 pm IST
|
5-day change
|
1st Jan Change
|
8,045
TRY
|
+0.56%
|
|
-8.14%
|
-47.74%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
135
|
288.8
|
1,530
|
2,087
|
5,250
|
57,731
|
Enterprise Value (EV)
1 |
130.2
|
285.5
|
1,525
|
2,082
|
5,223
|
57,727
|
P/E ratio
|
13.8
x
|
72.1
x
|
112
x
|
68.1
x
|
83.1
x
|
-2,069
x
|
Yield
|
3.37%
|
1.04%
|
-
|
0.18%
|
-
|
-
|
Capitalization / Revenue
|
2.44
x
|
5.45
x
|
19.9
x
|
14.1
x
|
16.5
x
|
122
x
|
EV / Revenue
|
2.35
x
|
5.38
x
|
19.8
x
|
14
x
|
16.4
x
|
122
x
|
EV / EBITDA
|
10.2
x
|
36.5
x
|
80.7
x
|
58.8
x
|
62.6
x
|
1,241
x
|
EV / FCF
|
-
|
47,74,59,198
x
|
17,87,18,560
x
|
59,68,58,574
x
|
42,93,30,507
x
|
93,52,51,459
x
|
FCF Yield
|
-
|
0%
|
0%
|
0%
|
0%
|
0%
|
Price to Book
|
4.41
x
|
9.24
x
|
37.7
x
|
29.6
x
|
40.5
x
|
287
x
|
Nbr of stocks (in thousands)
|
3,750
|
3,750
|
3,750
|
3,750
|
3,750
|
3,750
|
Reference price
2 |
36.00
|
77.00
|
408.0
|
556.5
|
1,400
|
15,395
|
Announcement Date
|
16/11/18
|
21/11/19
|
07/12/20
|
16/02/23
|
16/02/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
55.38
|
53.03
|
76.98
|
148.2
|
318.9
|
472.9
|
EBITDA
1 |
12.71
|
7.824
|
18.91
|
35.38
|
83.47
|
46.5
|
EBIT
1 |
11.46
|
5.858
|
16.98
|
33.45
|
80.85
|
37.2
|
Operating Margin
|
20.69%
|
11.05%
|
22.06%
|
22.57%
|
25.36%
|
7.87%
|
Earnings before Tax (EBT)
1 |
13.27
|
5.57
|
17.87
|
36.21
|
81.4
|
-12.41
|
Net income
1 |
9.791
|
4.004
|
13.61
|
30.66
|
63.21
|
-27.91
|
Net margin
|
17.68%
|
7.55%
|
17.68%
|
20.69%
|
19.82%
|
-5.9%
|
EPS
2 |
2.611
|
1.068
|
3.630
|
8.177
|
16.86
|
-7.442
|
Free Cash Flow
|
-
|
0.598
|
8.533
|
3.488
|
12.17
|
61.72
|
FCF margin
|
-
|
1.13%
|
11.09%
|
2.35%
|
3.82%
|
13.05%
|
FCF Conversion (EBITDA)
|
-
|
7.64%
|
45.13%
|
9.86%
|
14.57%
|
132.74%
|
FCF Conversion (Net income)
|
-
|
14.94%
|
62.69%
|
11.37%
|
19.25%
|
-
|
Dividend per Share
2 |
1.213
|
0.8000
|
-
|
1.000
|
-
|
-
|
Announcement Date
|
16/11/18
|
21/11/19
|
07/12/20
|
16/02/23
|
16/02/23
|
26/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
4.85
|
3.21
|
4.91
|
5.32
|
27
|
3.75
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0.6
|
8.53
|
3.49
|
12.2
|
61.7
|
ROE (net income / shareholders' equity)
|
-
|
12.9%
|
37.9%
|
44.8%
|
63.1%
|
-12.9%
|
ROA (Net income/ Total Assets)
|
-
|
8.96%
|
21.7%
|
24%
|
36.6%
|
7.8%
|
Assets
1 |
-
|
44.69
|
62.84
|
127.9
|
172.9
|
-357.6
|
Book Value Per Share
2 |
8.150
|
8.340
|
10.80
|
18.80
|
34.60
|
53.60
|
Cash Flow per Share
2 |
1.300
|
0.8600
|
2.630
|
2.750
|
8.400
|
12.40
|
Capex
1 |
6.24
|
2.19
|
0.88
|
3.97
|
1.9
|
4.5
|
Capex / Sales
|
11.27%
|
4.14%
|
1.15%
|
2.68%
|
0.6%
|
0.95%
|
Announcement Date
|
16/11/18
|
21/11/19
|
07/12/20
|
16/02/23
|
16/02/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -47.74% | 92Cr | | +18.81% | 6.73TCr | | +23.71% | 4.37TCr | | +37.17% | 2.81TCr | | +8.52% | 1.92TCr | | +15.26% | 1.72TCr | | -27.02% | 1.46TCr | | -14.48% | 1.45TCr | | -32.66% | 1.16TCr | | -32.82% | 1.14TCr |
Other Specialty Chemicals
|